The Gut Microbiome: An Overview

Anderson, G., & Maes, M. (2015). The gut–brain axis: The role of melatonin in linking psychiatric, inflammatory and neurodegenerative conditions. Advances in Integrative Medicine, 2(1), 31–37. https://doi.org/10.1016/j.aimed.2014.12.007

Auteri, M., Zizzo, M. G., & Serio, R. (2015). GABA and GABA receptors in the gastrointestinal tract: From motility to inflammation. Pharmacological Research, 93, 11–21. https://doi.org/10.1016/j.phrs.2014.12.001

Bauer, H., Horowitz, R. E., Lewensen, S. M., & Popper, H. (1963). Response of the lymphatic tissue to the microbial flora. Studies on germ free mice. Am. J. Pathol, 42, 471–483.

Bentley, R., & Meganathan, R. (1982). Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiological Reviews, 46(3), 241–280. https://doi.org/10.1128/mr.46.3.241-280.1982

Berg, G., Rybakova, D., Lima, N., Loy, A., Macklin, J. A., Maguin, E., Mauchline, T., McClure, R., Schloter, M. (2020). Microbiome definition re-visited: Old concepts and new challenges. Microbiome, 8(1). https://doi.org/10.1186/s40168-020-00875-0

Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2017). Gut microbiome and liver disease. Translational Research, 179, 49–59. https://doi.org/10.1016/j.trsl.2016.07.005

Bocci, V. (1992). The neglected organ: Bacterial Flora has a crucial immunostimulatory role. Perspectives in Biology and Medicine, 35(2), 251–260. https://doi.org/10.1353/pbm.1992.0004

Brandl, K., Kumar, V., & Eckmann, L. (2017). Gut-liver axis at the frontier of host-microbial interactions. American Journal of Physiology-Gastrointestinal and Liver Physiology, 312(5). https://doi.org/10.1152/ajpgi.00361.2016

Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018). Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders. Frontiers in Psychiatry, 9. https://doi.org/10.3389/fpsyt.2018.00044

Britton, G. J., Contijoch, E. J., Clemente, J. C., Grinspan, A., Sands, B. E., Colombel, J.-F., … Faith, J. J. (2019). Microbiotas from humans with inflammatory bowel disease alter the balance of gut th17 and rorγt+ regulatory T cells and exacerbate colitis in mice. Immunity, 50(1). https://doi.org/10.1016/j.immuni.2018.12.015

Burke, K. E., & Lamont, J. T. (2014). clostridium difficile infection: A worldwide disease. Gut and Liver, 8(1), 1–6. https://doi.org/10.5009/gnl.2014.8.1.1

Cani, P. D., & Knauf, C. (2016). How gut microbes talk to organs: The role of endocrine and nervous routes. Molecular Metabolism, 5(9), 743–752. https://doi.org/10.1016/j.molmet.2016.05.011

Cani, P. D., Amar, J., Iglesias, M, Chamontin, B., Ferrières Jean, Tanti Jean-François, Gibson, G. R., Casteilla, L., … Burcelin Rémy. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56(7), 1761–1772. https://doi.org/10.2337/db06-1491

Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015). Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health & Disease, 26. https://doi.org/10.3402/mehd.v26.26191

Cassard, A.-M., & Ciocan, D. (2018). Microbiota, a key player in alcoholic liver disease. Clinical and Molecular Hepatology, 24(2), 100–107. https://doi.org/10.3350/cmh.2017.0067

Chen, Z., Radjabzadeh, D., Uitterlinden, A. G., Zhernakova, A., Fu, J., Kraaij, R., & Voortman, T. (2021). Association of insulin resistance and type 2 diabetes with gut microbial diversity. JAMA Network Open, 4(7). https://doi.org/10.1001/jamanetworkopen.2021.18811

Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012). The impact of the gut microbiota on human health: An integrative view. Cell, 148(6), 1258–1270. https://doi.org/10.1016/j.cell.2012.01.035

Collins, S. L., & Patterson, A. D. (2020). The gut microbiome: An orchestrator of xenobiotic metabolism. Acta Pharmaceutica Sinica B, 10(1), 19–32. https://doi.org/10.1016/j.apsb.2019.12.001

Covasa, M., Stephens, R. W., Toderean, R., & Cobuz, C. (2019). Intestinal sensing by gut microbiota: Targeting gut peptides. Frontiers in Endocrinology, 10. https://doi.org/10.3389/fendo.2019.00082

de J.R. De-Paula, V., Forlenza, A. S., & Forlenza, O. V. (2018). Relevance of gut microbiota in cognition, behaviour and alzheimer's disease. Pharmacological Research, 136, 29–34. https://doi.org/10.1016/j.phrs.2018.07.007

Di Domenico, M., Ballini, A., Boccellino, M., Scacco, S., Lovero, R., Charitos, I. A., & Santacroce, L. (2022). The intestinal microbiota may be a potential theranostic tool for personalized medicine. Journal of Personalized Medicine, 12(4), 523. https://doi.org/10.3390/jpm12040523

Doulberis, M., Kotronis, G., Gialamprinou, D., Kountouras, J., & Katsinelos, P. (2017). Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism, 71, 182–197. https://doi.org/10.1016/j.metabol.2017.03.013

Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science, 308(5728), 1635–1638. https://doi.org/10.1126/science.1110591

Fenn, K., Strandwitz, P., Stewart, E. J., Dimise, E., Rubin, S., Gurubacharya, S., Clardy, J., & Lewis, K. (2017). Quinones are growth factors for the human gut microbiota. Microbiome, 5(1). https://doi.org/10.1186/s40168-017-0380-5

Forssten, S. D., & Ouwehand, A. C. (2022). Contribution of the microbiota to Healthy Aging. Comprehensive Gut Microbiota, 69–84. https://doi.org/10.1016/b978-0-12-819265-8.00059-0

Framework for human microbiome research. (2012). Nature, 486(7402), 215–221. https://doi.org/10.1038/nature11209

Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences, 104(34), 13780–13785. https://doi.org/10.1073/pnas.0706625104

Gavini, F., Cayuela, C., & Neut, C. (2001). Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microbial Ecology in Health and Disease, 13(1), 40–45. https://doi.org/10.1080/089106001750071690

Ge, X., Pan, J., Liu, Y., Wang, H., Zhou, W., & Wang, X. (2018). Intestinal crosstalk between microbiota and serotonin and its impact on Gut Motility. Current Pharmaceutical Biotechnology, 19(3), 190–195. https://doi.org/10.2174/1389201019666180528094202

Gensollen, T., Iyer, S. S., Kasper, D. L., & Blumberg, R. S. (2016). How colonization by Microbiota in early life shapes the immune system. Science, 352(6285), 539–544. https://doi.org/10.1126/science.aad9378

Ghattargi, V. C., Sape, K., Kumbhare, S. V., & Shouche, Y. S. (2019). Mining human microbiome for therapeutics. Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications, 573–613. https://doi.org/10.1007/978-981-13-8315-1_18

Gomez de Agüero, M., Hapfelmeier, S., Sauer, U., McCoy, K. D., & Macpherson, A. J. (2016). The maternal microbiota drives early postnatal innate immune development. Science, 351(6279), 1296–1302. https://doi.org/10.1126/science.aad2571

Hapfelmeier, S., Lawson, M. A., Velykoredko, Y., Balmer, M. L., Endt, K., Geuking, M. B., Curtiss, R., McCoy, K. D., & Macpherson, A. J. (2010). Reversible microbial colonization of germ-free mice reveals the dynamics of Iga Immune Responses. Science, 328(5986), 1705–1709. https://doi.org/10.1126/science.1188454

Holscher, H. D. (2017). Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes, 8(2), 172–184. https://doi.org/10.1080/19490976.2017.1290756

Indiani, C. M., Rizzardi, K. F., Castelo, P. M., Ferraz, L. F., Darrieux, M., & Parisotto, T. M. (2018). Childhood obesity and Firmicutes/bacteroidetes ratio in the gut microbiota: A systematic review. Childhood Obesity, 14(8), 501–509. https://doi.org/10.1089/chi.2018.0040

Izuddin, W. I., Humam, A. M., Loh, T. C., Foo, H. L., & Samsudin, A. A. (2020). Dietary postbiotic lactobacillus plantarum improves serum and ruminal antioxidant activity and upregulates hepatic antioxidant enzymes and ruminal barrier function in post-weaning lambs. Antioxidants, 9(3), 250. https://doi.org/10.3390/antiox9030250

Kaelberer, M. M., Rupprecht, L. E., Liu, W. W., Weng, P., & Bohórquez, D. V. (2020). Neuropod cells: The emerging biology of gut-brain sensory transduction. Annual Review of Neuroscience, 43(1), 337–353. https://doi.org/10.1146/annurev-neuro-091619-022657

Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013). Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews Immunology, 13(5), 321–335. https://doi.org/10.1038/nri3430

Kim, C. Y., Ma, J., & Lee, I. (2022). HiFi metagenomic sequencing enables assembly of accurate and complete genomes from human gut microbiota. https://doi.org/10.1101/2022.02.09.479829

Kim, Y. S., & Ho, S. B. (2010). Intestinal goblet cells and mucins in health and disease: Recent insights and progress. Current Gastroenterology Reports, 12(5), 319–330. https://doi.org/10.1007/s11894-010-0131-2

LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., & Ventura, M. (2013). Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Current Opinion in Biotechnology, 24(2), 160–168. https://doi.org/10.1016/j.copbio.2012.08.005

Ley, R. E., Knight, R., & Gordon, J. I. (2007). The human microbiome: Eliminating the biomedical/environmental dichotomy in Microbial Ecology. Environmental Microbiology, 9(1), 3–4. https://doi.org/10.1111/j.1462-2920.2006.01222_3.x

Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell, 124(4), 837–848. https://doi.org/10.1016/j.cell.2006.02.017

Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006). Human gut microbes associated with obesity. Nature, 444(7122), 1022–1023. https://doi.org/10.1038/4441022a

Liu, Y., Wang, J., & Wu, C. (2022). Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics. Frontiers in Nutrition, 8. https://doi.org/10.3389/fnut.2021.634897

Macpherson, A. J., & Uhr, T. (2004). Induction of protective IGA by intestinal dendritic cells carrying commensal bacteria. Science, 303(5664), 1662–1665. https://doi.org/10.1126/science.1091334

Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V. D., Sokol, H., Doré, J., Corthier, G., & Furet, J.-P. (2009). The Firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology, 9(1), 123. https://doi.org/10.1186/1471-2180-9-123

Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013). Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell, 152(1-2), 39–50. https://doi.org/10.1016/j.cell.2012.10.052

Merriam-Webster. (n.d.). Microbiome definition & meaning. Merriam-Webster. Retrieved June 22, 2022, from https://www.merriam-webster.com/dictionary/microbiome

Metges, C. C. (2000). Contribution of microbial amino acids to amino acid homeostasis of the host. The Journal of Nutrition, 130(7). https://doi.org/10.1093/jn/130.7.1857s

Misiak, B., Łoniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020). The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 102, 109951. https://doi.org/10.1016/j.pnpbp.2020.109951

Mitsuoka, T. (2014). Decline in Microbial Diversity and Richness of the Microbiome with Age. Biosci.Microbiota Food Health, 33, 99–116.

Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2020). The gut microbiota–brain axis in behaviour and brain disorders. Nature Reviews Microbiology, 19(4), 241–255. https://doi.org/10.1038/s41579-020-00460-0

Morrison, D. J., & Preston, T. (2016). Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes, 7(3), 189–200. https://doi.org/10.1080/19490976.2015.1134082

Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005). Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology, 3(5), 431–438. https://doi.org/10.1038/nrmicro1152

Odamaki, T., Kato, K., Abe, F., & Osawa, R. (2016). Age-related changes in gut microbiota composition from newborn to Centenarian: A cross-sectional study. BMC Microbiology, 16(1). https://doi.org/10.1186/s12866-016-0708-5

O'Hara, A. M., & Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Reports, 7(7), 688–693. https://doi.org/10.1038/sj.embor.7400731

Owyang, C., & Logsdon, C. D. (2004). New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology, 127(3), 957–969. https://doi.org/10.1053/j.gastro.2004.05.002

Pham,V. T., Dold, S., Rehman, A., Bird, J. K., & Steinert, R. E. (2021). Vitamins, the gut microbiome and gastrointestinal health in humans. Nutrition Research, 95, 35–53. https://doi.org/10.1016/j.nutres.2021.09.001

Ponziani, F. R., Bhoori, S., Calvani, R., Camisaschi, C., Picca, A., Tuccitto, A., Gasbarrini, A., Pompili, M., & Mazzaferro, V. (2018). Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology, 69(1), 107–120. https://doi.org/10.1002/hep.30036

Ramakrishna, B. S. (2013). Role of the gut microbiota in human nutrition and metabolism. Journal of Gastroenterology and Hepatology, 28, 9–17. https://doi.org/10.1111/jgh.12294

Ritter, R. C. (2004). Gastrointestinal mechanisms of satiation for food. Physiology & Behavior, 81(2), 249–273. https://doi.org/10.1016/j.physbeh.2004.02.012

Rodríguez-Romero, J. de, Durán-Castañeda, A. C., Cárdenas-Castro, A. P., Sánchez-Burgos, J. A., Zamora-Gasga, V. M., & Sáyago-Ayerdi, S. G. (2022). What we know about protein gut metabolites: Implications and insights for human health and diseases. Food Chemistry: X, 13, 100195. https://doi.org/10.1016/j.fochx.2021.100195

Rogers, Y.-H., & Zhang, C. (2016). Genomic Technologies in Medicine and Health. Medical and Health Genomics, 15–28. https://doi.org/10.1016/b978-0-12-420196-5.00002-2

Round, J. L., & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology, 9(5), 313–323. https://doi.org/10.1038/nri2515

Régnier, M., Hul, M. V., Knauf, C., & Cani, P. D. (2021). Gut microbiome, endocrine control of gut barrier function and Metabolic Diseases. Journal of Endocrinology, 250(1). https://doi.org/10.1530/joe-20-0473e

Sarada, J., Anju, S., Aparna, Y., & Anuradha, K. (2021). Microbiome therapeutics: Emerging concepts and challenges. Microbiome in Human Health and Disease, 217–238. https://doi.org/10.1007/978-981-16-3156-6_11

Schroeder, B. O., & Bäckhed, F. (2016). Signals from the gut microbiota to distant organs in physiology and disease. Nature Medicine, 22(10), 1079–1089. https://doi.org/10.1038/nm.4185

Shah, A., Shanahan, E., Macdonald, G., Fletcher, L., Ghasemi, P., Morrison, M., Jones, M., & Holtmann, G. (2017). Systematic Review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in chronic liver disease. Seminars in Liver Disease, 37(04), 388–400. https://doi.org/10.1055/s-0037-1608832

Shasthry, S. M. (2020). Fecal microbiota transplantation in alcohol related liver diseases. Clinical and Molecular Hepatology, 26(3), 294–301. https://doi.org/10.3350/cmh.2020.0057

Sherman, P. M., Ossa, J. C., & Johnson-Henry, K. (2009). Unraveling mechanisms of action of probiotics. Nutrition in Clinical Practice, 24(1), 10–14. https://doi.org/10.1177/0884533608329231

Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology, 145(5), 946–953. https://doi.org/10.1053/j.gastro.2013.08.058

Srivastava, N., Gupta, B., Gupta, S2012., Danquah, M. K., & Sarethy, I. P. (2019). Analyzing functional microbial diversity. Microbial Diversity in the Genomic Era, 79–102. https://doi.org/10.1016/b978-0-12-814849-5.00006-x

Strandwitz, P. (2018). Neurotransmitter modulation by the gut microbiota. Brain Research, 1693, 128–133. https://doi.org/10.1016/j.brainres.2018.03.015

Sun, C., Chen, L., & Shen, Z. (2019). Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharmaceutical Journal, 27(8), 1146–1156. https://doi.org/10.1016/j.jsps.2019.09.011

Tanabe, S. (2013). The effect of probiotics and gut microbiota on th17 cells. International Reviews of Immunology, 32(5-6), 511–525. https://doi.org/10.3109/08830185.2013.839665

Tang, R., Wei, Y., Xiao, X., Fan, Z., Wu, M., Qiu, D., Fang, J.-Y., Ansari, A, Ma, X. (2017). Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut, 67(3), 534–541. https://doi.org/10.1136/gutjnl-2016-313332

Tang, W. H., & Hazen, S. L. (2017). The gut microbiome and its role in cardiovascular diseases. Circulation, 135(11), 1008–1010. https://doi.org/10.1161/circulationaha.116.024251

Thomas, C. M., Hong, T., Hu, W., Britton, R. A., Kalkum, M., & Versalovic, J. (2012). Histamine derived from probiotic lactobacillus reuteri suppresses TNF via modulation of PKA and Erk Signaling. PLoS ONE, 7(2). https://doi.org/10.1371/journal.pone.0031951

Tomasello, G., Mazzola, M., Jurjus, A., Carini, F., Damiani, P., Geagea, A. G., Zeeny, M. N., & Leone, A. (2017). The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping. J. Biol Regul Homeost Agents 31(1), 245–249.

Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. I. (2007). The Human Microbiome Project. Nature, 449(7164), 804–810. https://doi.org/10.1038/nature06244

Udayappan, S. D., Hartstra, A. V., Dallinga-Thie, G. M., & Nieuwdorp, M. (2014). Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clinical and Experimental Immunology, 177(1), 24–29. https://doi.org/10.1111/cei.12293

U.S. Food and Drug Administration. (2016) Use of fecal microbiota for transplantation (FMT) to treat clostridium.. Retrieved from https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/use-fecal-microbiota-transplantation-fmt-treat-clostridium-difficile-infection-not-responsive

Wesemann, D. R., Portuguese, A. J., Magee, J. M., Panchakshari, R. A., Rodig, S. J., Kepler, T. B., & Alt, F. W. (2013). Microbial colonization influences early B-lineage development in the gut lamina propria. Nature, 501(7465), 112–115. https://doi.org/10.1038/nature12496

Whipps, J. M. (n.d.). Mycoparasitism and plant disease control. In N. Burge (Ed.), Fungi Biol Control Syst. (pp. 161–187). Essay, Manchester: Manchester University Press.

Woese, C. R., & Fox, G. E. (1977). Phylogenetic structure of the prokaryotic domain: The primary kingdoms. Proceedings of the National Academy of Sciences, 74(11), 5088–5090. https://doi.org/10.1073/pnas.74.11.5088

Zhang, X., Zhivaki, D., & Lo-Man, R. (2017). Unique aspects of the perinatal immune system. Nature Reviews Immunology, 17(8), 495–507. https://doi.org/10.1038/nri.2017.54

Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019). Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature, 570(7762), 462–467. https://doi.org/10.1038/s41586-019-1291-3

Zou, Y., Wang, J., Lv, H., & Wang, S. (2020). Protection of galacto-oligosaccharide against E. coli O157 colonization through enhancing gut barrier function and modulating gut microbiota. Foods, 9(11), 1710. https://doi.org/10.3390/foods9111710